Visit-to-visit HbA1c variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention

Chen Die Yang,Ying Shen,Lin Lu,Zhen Kun Yang,Jian Hu,Rui Yan Zhang,Wei Feng Shen,Feng Hua Ding,Xiao Qun Wang
DOI: https://doi.org/10.1186/s12933-020-01111-7
IF: 8.949
2020-09-04
Cardiovascular Diabetology
Abstract:Abstract Background Patients with type 2 diabetes are under substantially higher risk of in-stent restenosis (ISR) after coronary stent implantation. We sought to investigate whether visit-to-visit HbA 1c variability is a potential predictor of ISR in diabetic patients after stent implantation. Methods We consecutively enrolled type 2 diabetic patients who underwent successful elective percutaneous coronary intervention and performed follow-up coronary angiography after around 12 months. The incidence of ISR and its relationship with visit-to-visit HbA 1c variability, expressed as coefficient of variation (CV), standard deviation (SD) and variability independent of the mean (VIM), were studied. Multivariable Cox proportional hazards models were constructed to analyze the predictive value of HbA 1c variability for ISR. Results From September 2014 to July 2018 in Ruijin Hospital, a total of 420 diabetic patients (688 lesions) after stent implantation were included in the final analysis. During a mean follow-up of 12.8 ± 1.3 months, the incidence of ISR was 8.6%, which was significantly increased in patients with higher CV of HbA 1c ( P = 0.001). The mean diameter stenosis (DS), net luminal loss and net luminal gain were 22.9 ± 16.8%, 0.42 ± 0.88 mm and 1.66 ± 0.83 mm, respectively. Greater DS was observed in subjects with higher tertiles of CV of HbA 1c ( P < 0.001), and this trend was more prominent in patients with optimal glycemic control (HbA 1c ≤ 7%) in the baseline. In multivariate analysis, HbA 1c variability was independently associated with incidence of ISR after adjustment for traditional risk factors and mean HbA 1c (HR: 3.00 [95% CI 1.14–7.92] for highest vs. lowest tertile). Inclusion of CV of HbA 1c led to a better risk stratification accuracy. Assessing HbA 1c variability by SD or VIM yielded similar findings. Conclusions This study suggests that visit-to-visit HbA 1c variability is an independent predictor of incidence of ISR in patients with type 2 diabetes after stent implantation. Trial registration NCT02089360: NCT
cardiac & cardiovascular systems,endocrinology & metabolism
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore whether the change of glycated hemoglobin (HbA1c) during the follow - up period can be a potential predictor of in - stent restenosis (ISR) in diabetic patients after coronary artery stenting. Specifically, the researchers focused on the relationship between the fluctuation of HbA1c (measured by coefficient of variation CV, standard deviation SD and variability independent of the mean VIM) and the incidence of ISR. ### Research Background Patients with type 2 diabetes have a significantly increased risk of in - stent restenosis after coronary artery stenting. Hyperglycemia is considered one of the key factors leading to restenosis, partly due to endothelial dysfunction, excessive production of reactive oxygen species and the formation of advanced glycation end products. Previous studies have shown that good preoperative blood - glucose control is associated with a lower stent failure rate. However, the impact of blood - glucose fluctuation on diabetic complications is still unclear, especially in patients with coronary artery disease, where both short - term and long - term blood - glucose fluctuations are associated with poor prognosis. Therefore, this study aims to explore whether the fluctuation of HbA1c can be a potential predictor of ISR in patients with type 2 diabetes after drug - eluting stent implantation. ### Methods The study included 420 patients with type 2 diabetes who underwent coronary angiography and drug - eluting stent implantation at Shanghai Ruijin Hospital from September 2014 to July 2018. These patients had a follow - up coronary angiography approximately 12 months after the operation. The researchers analyzed the incidence of ISR and its relationship with HbA1c fluctuation, and used a multivariate Cox proportional - hazards model to analyze the predictive value of HbA1c fluctuation for ISR. ### Results During the follow - up period of an average of 12.8 ± 1.3 months, the incidence of ISR was 8.6% and was significantly increased in patients with a higher coefficient of variation of HbA1c (P = 0.001). Multivariate analysis showed that the fluctuation of HbA1c was independently associated with the incidence of ISR (highest tertile compared with the lowest tertile, HR: 3.00 [95% CI 1.14–7.92]). After considering the fluctuation of HbA1c, the accuracy of risk stratification was improved. ### Conclusions This study shows that the fluctuation of HbA1c during the follow - up period is an independent predictor of ISR in patients with type 2 diabetes after drug - eluting stent implantation. This finding helps to better understand the impact of blood - glucose fluctuation on the cardiovascular health of diabetic patients and may provide a new basis for clinical decision - making.